Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for HLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 115.90M
March 31, 2026 106.00M
December 31, 2025 91.90M
September 30, 2025 97.80M
June 30, 2025 96.20M
March 31, 2025 90.10M
December 31, 2024 68.90M
September 30, 2024 82.00M
June 30, 2024 82.80M
March 31, 2024 87.90M
December 31, 2023 81.20M
September 30, 2023 79.50M
June 30, 2023 86.30M
March 31, 2023 85.10M
December 31, 2022 70.60M
September 30, 2022 85.00M
June 30, 2022 83.40M
March 31, 2022 84.00M
December 31, 2021 66.90M
September 30, 2021 85.90M
June 30, 2021 107.40M
March 31, 2021 101.30M
December 31, 2020 83.30M
September 30, 2020 109.30M
June 30, 2020 105.90M
Date Value
March 31, 2020 79.20M
December 31, 2019 79.70M
September 30, 2019 100.40M
June 30, 2019 98.10M
March 31, 2019 92.60M
December 31, 2018 70.50M
September 30, 2018 99.40M
June 30, 2018 100.00M
March 31, 2018 103.30M
December 31, 2017 93.30M
September 30, 2017 95.20M
June 30, 2017 89.70M
March 31, 2017 100.20M
December 31, 2016 70.30M
September 30, 2016 87.90M
June 30, 2016 94.10M
March 31, 2016 89.90M
December 31, 2015 69.90M
September 30, 2015 89.90M
June 30, 2015 96.50M
March 31, 2015 86.80M
December 31, 2014 83.60M
September 30, 2014 100.56M
June 30, 2014 103.78M
March 31, 2014 118.61M

Accounts Receivable Definition

Represents change in working capital due to increase or decrease in receivables for the given period.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Nu Skin Enterprises, Inc. 48.90M
Joey New York, Inc. --
Merion, Inc. --
Warpaint London Plc --
USANA Health Sciences, Inc. 3.337M